NUBPL (Gene)

Synonyms:C14orf127, ENTREZ:80224, HGNC:20278, IND1, MC1DN21, MIM:613621, NM_001201573, NM_001201574, NM_025152, NP_001188502, NP_001188503, NP_079428, NR_120408, NUBPL, XM_011537181, XM_011537182, XM_011537183, XM_011537184, XM_017021664, XM_017021665, XM_017021666, XM_017021667, XP_011535483, XP_011535484, XP_011535485, XP_011535486, XP_016877153, XP_016877154, XP_016877155, XP_016877156, huInd1, nucleotide binding protein like
Omim:OMIM:613621
Id:ENSG00000151413
Hgnc:HGNC:20278
Entrez:80224
Description:NUBP iron-sulfur cluster assembly factor, mitochondrial
This gene encodes a member of the Mrp/NBP35 ATP-binding proteins family. The encoded protein is required for the assembly of the respiratory chain NADH dehydrogenase (complex I), an oligomeric enzymatic complex located in the inner mitochondrial membrane. Mutations in this gene cause mitochondrial complex I deficiency. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View NUBPL's neighborhood in the knowledge graph.

Playbook Workflow Builder
Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with NUBPL.

Gene Partnership Appyter
CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using NUBPL.

Gene and Drug Landing Page Aggregator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for NUBPL.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with NUBPL.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.